SEATTLE, June 2, 2012 /PRNewswire/ - Oncothyreon Inc.

CHICAGO, June 2, 2012 /PRNewswire/ -- Results observed from pre-specified interim analyses of the randomized, placebo-controlled Phase 3 study, COU-AA-302, demonstrated that

With a variety of trials or studies available, Diagnostics Research Group is looking for subjects to participate in clinical trials. San Antonio, TX (PRWEB)

This press release does not constitute an offer to sell or the solicitation of offers to buy any securities of Inovio, and shall not constitute an offer, solicitation or sale of any security in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

INDIANAPOLIS, June 1, 2012 /PRNewswire/ -- Today, Eli Lilly and Company (NYSE: LLY) launched a searchable clinical trial mobile application for oncology healthcare professionals.